Literature DB >> 33478328

Hypoxia activated long non-coding RNA HABON regulates the growth and proliferation of hepatocarcinoma cells by binding to and antagonizing HIF-1 alpha.

Cheng-Ning Ma1, Lu-Lu Wo1, Di-Fei Wang1, Ci-Xiang Zhou1, Jing-Chi Li1, Xin Zhang1, Xiu-Feng Gong1, Chen-Long Wang2, Ming He1, Qian Zhao1.   

Abstract

The adaptation of tumour cells to hypoxic microenvironment is one of the most significant characteristics of many malignant tumour diseases including hepatocarcinoma. Recently, long non-coding RNAs (lncRNAs) have been reported to play important roles in the various levels of gene regulation thus functioning in growth and survival of tumour cells. Here, new hypoxia-related lncRNAs in hepatocarcinoma cells were screened and validated by lncRNA chip-array as well as real-time RT-PCR. Among them, a hypoxia-activated lncRNA that we identified and termed Hypoxia-Activated BNIP3 Overlapping Non-coding RNA (HABON), was not only regulated by hypoxic-induced factor-1α (HIF-1α) but its expression increased significantly under hypoxia in tumour cells. We deciphered the biological characteristics of HABON including its cell localization, genomic location, as well as its full-length sequence, and proved HABON could promote growth, proliferation and clone-formation of hepatocarcinoma cells under hypoxia. Then, we revealed that HABON was transcriptionally activated by HIF-1α in hypoxic cells, furthermore, it could interact with HIF-1α and promote its protein degradation, thus affecting transcription of HIF-1α's target genes to exert its effects on cells. Besides, the elevated expression of HABON under hypoxia could promote the transcriptional activation of BNIP3 through HIF-1α, and increasing the expression level of BNIP3. This research provides a novel clue for the adaptive survival and growth mechanism of tumour under hypoxia, and gives a way to reveal the nature of tumour cells' resistance characteristics to harsh microenvironment.

Entities:  

Keywords:  BNIP3; HABON; HIF-1α; Hepatocarcinoma; hypoxia; lncRNA

Mesh:

Substances:

Year:  2021        PMID: 33478328      PMCID: PMC8583305          DOI: 10.1080/15476286.2020.1871215

Source DB:  PubMed          Journal:  RNA Biol        ISSN: 1547-6286            Impact factor:   4.652


  72 in total

Review 1.  Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy.

Authors:  Gregg L Semenza
Journal:  Trends Pharmacol Sci       Date:  2012-03-06       Impact factor: 14.819

2.  Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1.

Authors:  J A Forsythe; B H Jiang; N V Iyer; F Agani; S W Leung; R D Koos; G L Semenza
Journal:  Mol Cell Biol       Date:  1996-09       Impact factor: 4.272

Review 3.  Regulation of metabolism by hypoxia-inducible factor 1.

Authors:  G L Semenza
Journal:  Cold Spring Harb Symp Quant Biol       Date:  2011-07-22

4.  Long noncoding RNA HOTAIR, a hypoxia-inducible factor-1α activated driver of malignancy, enhances hypoxic cancer cell proliferation, migration, and invasion in non-small cell lung cancer.

Authors:  Chunxia Zhou; Lincai Ye; Chuan Jiang; Jie Bai; Yongbin Chi; Haibo Zhang
Journal:  Tumour Biol       Date:  2015-06-19

5.  Signal transduction in hypoxic cells: inducible nuclear translocation and recruitment of the CBP/p300 coactivator by the hypoxia-inducible factor-1alpha.

Authors:  P J Kallio; K Okamoto; S O'Brien; P Carrero; Y Makino; H Tanaka; L Poellinger
Journal:  EMBO J       Date:  1998-11-16       Impact factor: 11.598

6.  Modulation of hypoxia-signaling pathways by extracellular linc-RoR.

Authors:  Kenji Takahashi; Irene K Yan; Hiroaki Haga; Tushar Patel
Journal:  J Cell Sci       Date:  2014-01-24       Impact factor: 5.285

7.  Urothelial carcinoma associated 1 is a hypoxia-inducible factor-1α-targeted long noncoding RNA that enhances hypoxic bladder cancer cell proliferation, migration, and invasion.

Authors:  Mei Xue; Xu Li; Zhengkun Li; Wei Chen
Journal:  Tumour Biol       Date:  2014-04-16

Review 8.  Therapeutic targeting of non-coding RNAs in cancer.

Authors:  Ondrej Slaby; Richard Laga; Ondrej Sedlacek
Journal:  Biochem J       Date:  2017-12-14       Impact factor: 3.857

Review 9.  Targeting HIF-1 for cancer therapy.

Authors:  Gregg L Semenza
Journal:  Nat Rev Cancer       Date:  2003-10       Impact factor: 60.716

10.  Oncofetal H19 RNA promotes tumor metastasis.

Authors:  Imad J Matouk; Eli Raveh; Rasha Abu-lail; Shaul Mezan; Michal Gilon; Eitan Gershtain; Tatiana Birman; Jennifer Gallula; Tamar Schneider; Moshe Barkali; Carmelit Richler; Yakov Fellig; Vladimir Sorin; Ayala Hubert; Abraham Hochberg; Abraham Czerniak
Journal:  Biochim Biophys Acta       Date:  2014-04-02
View more
  2 in total

1.  Comprehensive Analysis of Long Non-coding RNA and mRNA Transcriptomes Related to Hypoxia Adaptation in Tibetan Sheep.

Authors:  Zengkui Lu; Chao Yuan; Jianye Li; Tingting Guo; Yaojing Yue; Chune Niu; Jianbin Liu; Bohui Yang
Journal:  Front Vet Sci       Date:  2022-01-24

2.  An Effective Hypoxia-Related Long Non-Coding RNA Assessment Model for Prognosis of Lung Adenocarcinoma.

Authors:  Yuanshuai Li; Xiaofang Sun
Journal:  Front Genet       Date:  2022-03-16       Impact factor: 4.599

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.